Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 多克隆抗體
  4. HSD17B2 Antibody

HSD17B2 Antibody

  • 中文名稱：
    HSD17B2兔多克隆抗體
  • 貨號：
    CSB-PA010772GA01HU
  • 規(guī)格：
    ￥3,900
  • 其他：

產(chǎn)品詳情

  • Uniprot No.：
  • 基因名：
    HSD17B2
  • 別名：
    HSD17B2; EDH17B2; SDR9C2; 17-beta-hydroxysteroid dehydrogenase type 2; 17-beta-HSD 2; 20 alpha-hydroxysteroid dehydrogenase; 20-alpha-HSD; E2DH; Estradiol 17-beta-dehydrogenase 2; Microsomal 17-beta-hydroxysteroid dehydrogenase; Short chain dehydrogenase/reductase family 9C member 2; Testosterone 17-beta-dehydrogenase
  • 宿主：
    Rabbit
  • 反應種屬：
    Human
  • 免疫原：
    Human HSD17B2
  • 免疫原種屬：
    Homo sapiens (Human)
  • 抗體亞型：
    IgG
  • 純化方式：
    Antigen Affinity Purified
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
  • 產(chǎn)品提供形式：
    Liquid
  • 應用范圍：
    ELISA,WB,IHC
  • Protocols：
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

產(chǎn)品評價

靶點詳情

  • 功能：
    Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH.
  • 基因功能參考文獻：
    1. ATRA treatment decreased the mRNA expression of 17-beta-dehydrogenase 2 (HSD17B2) which converts estradiol into estrone in a dose-dependent manner PMID: 26228249
    2. Our findings suggested that CYP19A1 and HSD17B2 polymorphisms might be associated with circulating sex hormone levels in Japanese postmenopausal women, independent of current BMI. PMID: 26323233
    3. Data indicate that conversion of testosterone to 4-dione detected in abdominal adipose tissue is caused by 17b-HSD type 2 which is localized in the vasculature of the adipose compartment. PMID: 26123590
    4. This study demonstrated that HSD17B2 transcript and protein levels are linked to some clinicopathological features in gastric cancer. PMID: 25776474
    5. In both arm and subumbilical skin biopsy of patients with idiopathic hirsutism, there was an up-regulation of HSD17B2 mRNA expression. PMID: 26194504
    6. Single nucleotide polymorphism in HSD17B2 gene is associated with hepatocellular carcinoma. PMID: 24563232
    7. This study identified specific germline variations in estradiol metabolism-related pathways, namely CYP1B1, SULT2B1, and HSD17B2, as novel prognostic markers that are cumulatively associated with increased risk of prostate cancer progression PMID: 24682418
    8. SNP variants in the 17beta-HSD2 and 17beta-HSD7 genes and 17beta-HSD7 copy number is associated with increased estradiol levels in breast cancer tissues. PMID: 24560990
    9. overexpression of 17beta-HSD2 in sebocytes significantly increased the androstenedione production and markedly decreased the amounts of testosterone and dihydrotestosterone PMID: 24938708
    10. no significant difference in the genotype and allele frequencies of rs8191246 between uterine leiomyoma cases and controls PMID: 22546946
    11. Single-nucleotide polymorphisms in HSD17B2, HSD17B3 and HSD17B1 are associated with plasma testosterone level and prostate cancer aggressiveness. PMID: 21900597
    12. Data indicate that 17betaHSD2 expression is higher in HUAEC than in HUVEC; activity is higher in umbilical arteries near the placenta. These data are consistent with higher sex steroid inactivation in the arterial system of the foeto-placental unit. PMID: 21877158
    13. Data show that steroidogenic enzymes (AKR1C3, HSD17B2, UGT2B15 and UGT2B17) and stem/progenitor cell markers CK5 and ABCG2 were upregulated in castration resistant prostate cancer. PMID: 21365123
    14. Purification, reconstitution, and steady-state kinetics of the trans-membrane 17 beta-hydroxysteroid dehydrogenase 2. PMID: 11940569
    15. Androgen inactivation in human lung fibroblasts: variations in levels of 17 beta-hydroxysteroid dehydrogenase type 2 PMID: 12161528
    16. the lower expression of type 2 17 beta-HSD mRNA in scalp hairs of untreated hirsute patients suggests androgen metabolism disturbances with predominance of more potent androgens PMID: 12957669
    17. 17HSD type 2 mRNA expression in gastric mucosa of children compared to adults may be associated with increased need for protection against the mucosal load of foreign substances. The downregulation may have relevance in the pathogenesis of gastric cancer. PMID: 14666693
    18. Aromatase mRNA was higher in epithelial than in stromal cells in eutopic and ectopic endometrium in endometriosis. 17betaHSD2 in epithelial cells was increased during secretory phases compared with late proliferative phase. PMID: 16595205
    19. HSD17B2 expression in endometrial epithelial cells, and, therefore, estrogen inactivation, is regulated by SP1 and SP3, which are downstream targets of progesterone-dependent paracrine signals originating from endometrial stromal cells. PMID: 16807381
    20. importance of 17HSD type 2 in breast cancer- cell lines & non-tumour breast cells; high or low expression of 17HSD type 2 affected oestradiol concentration significantly; response was dependent on endogenous expression of 17HSD type 1 PMID: 16954436
    21. Previously unknown polymorphism was found in exon four of HSD17B2. Polymorphism does not contribute to a higher risk of developing breast cancer. PMID: 17260097
    22. The expression of 17beta-hydroxysteroid dehydrogenase type 2 (17beta-HSD2) in eutopic and ectopic endometrial tissues of women with endometriosis is reported. PMID: 17505937
    23. role for HSD17B2 in the action of retinoids, in addition to its oxidative HSD17B activity on sex steroids PMID: 17510238
    24. Data reported that a similar level of 17beta-hydroxysteroid dehydrogenase type 2 mRNA was found in Polycystic Ovary Syndrome and the control tissues. PMID: 17953976
    25. Overexpression in African-American breast cancer may contribute to the increased proportion of estrogen receptor-negative breast cancers and worse clinical outcome among African-American patients. PMID: 17993718
    26. The bone development in transgenic male mice ubiquitously expressing human HSD17B2, was studied. PMID: 18348690
    27. HSD17B2 germline mutations potentially involved in breast cancer predisposition. PMID: 18372405
    28. 17beta-HSD type 2 was expressed in 20% of breast cancer specimens. decrease in 17beta-HSD type 2 expressions in breast cancer may play a role in the development &/or progression of cancer by modifying the intratumoral levels of estrogens & androgens. PMID: 18996480
    29. preference of 17betaHSD2 for E2 oxidation strongly resists alteration by genetic & metabolic means. Findings suggest additional structural features, beyond lack of a specific Arg residue, disfavor NADPH binding & thus support E2 oxidation by 17betaHSD2 PMID: 19556422
    30. BRCA1 and HSD17B2 genes may increase the risk of developing breast cancer via enhanced estradiol activity. PMID: 19729830
    31. HSD17B2 modulates estrogen-independent and estrogen-dependent action in transgenic female mice. PMID: 19797119
    32. HSD17B2 mRNA is expressed in human skin, at higher levels in men than in women. Expression levels vary with skin sites. HSD17B2 levels are not altered by topical 17-beta-estradiol treatment. PMID: 18794456

    顯示更多

    收起更多

  • 亞細胞定位：
    Membrane; Single-pass type II membrane protein.
  • 蛋白家族：
    Short-chain dehydrogenases/reductases (SDR) family
  • 組織特異性：
    Expressed in placenta.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 5211

    OMIM: 109685

    KEGG: hsa:3294

    STRING: 9606.ENSP00000199936

    UniGene: Hs.162795